Grove Bank & Trust’s Ginkgo Bioworks DNA Stock Holding History

Grove Bank & Trust’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-36	Closed	-$2.62K	–	618
2023 Q3	$2.62K	Buy	+36	New	+$2.88K	﹤0.01%	625

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Grove Bank & Trust's DNA Position: Q4 2023 in Review

Grove Bank & Trust sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 36 shares — an estimated $2.62K sold.

Grove Bank & Trust first reported a position in DNA in Q3 2023 and held it in 1 quarter. The position peaked at $2.62K in Q3 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

Grove Bank & Trust reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
Grove Bank & Trust sold 36 Ginkgo Bioworks shares in Q4 2023, an estimated $2.62K.
Grove Bank & Trust first reported a position in Ginkgo Bioworks in Q3 2023 and held it in 1 quarter.
Grove Bank & Trust's Ginkgo Bioworks position peaked at $2.62K in Q3 2023.
342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on Grove Bank & Trust's 13F filing for Q4 2023, filed 30 Jan 2024.